Incannex Healthcare Inc.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $86.0K | $12.0K | — |
| Cost of Revenue | — | — | — |
| Gross Profit | — | — | — |
| Gross Margin | — | — | — |
| Operating Expenses | |||
| Research & Development | $10.7M | $12.9M | $6.3M |
| SG&A Expense | $13.1M | $17.2M | $8.0M |
| Operating Income | $-23.8M | $-30.0M | $-49.7M |
| Operating Margin | -27,661.6% | -250,341.7% | — |
| Interest Expense | — | — | — |
| Pretax Income | $-46.9M | $-18.4M | $-48.8M |
| Income Tax Expense | — | $30.0K | — |
| Net Income | $-46.9M | $-18.5M | $-48.8M |
| Net Margin | -54,517.4% | -153,825.0% | — |
| EPS (Basic) | $-1.35 | $-0.58 | $-1.66 |
| EPS (Diluted) | $-1.35 | $-0.58 | $-1.66 |
| Shares Outstanding (Basic) | 34.5M | 32.3M | 30.8M |
| Shares Outstanding (Diluted) | 34.5M | 32.3M | 30.8M |
| Dividends Per Share | — | — | — |